A randomized controlled, open-labelled early phase II trial comparing incidence of FOLFIRI.3-induced diarrhea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Hangeshashinto(TJ-14) Oral alkalization Primary outcome(s): the incidence of all grade of a late-onset diarrhea during the treatment period Study Design: Parallel Randomized
创建时间：
2008-11-15
